Effects of Pioglitazone on Insulin Sensitivity in Healthy Overweight and Obese Males (MK-0000-170)
Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether 30 mg of pioglitazone administered once
daily for up to 28 days to healthy overweight and obese subjects will lead to a significant
change in insulin sensitivity, measured in the setting of a hyperinsulinemic euglycemic clamp